BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 24442053)

  • 1. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
    Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.
    Puig S; Granger C; Garre A; Trullàs C; Sanmartin O; Argenziano G
    Dermatol Ther (Heidelb); 2019 Jun; 9(2):259-270. PubMed ID: 30968311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.
    Navarrete-Dechent C; Molgó M
    Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.
    Moscarella E; Argenziano G; Longo C; Aladren S
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e401-e403. PubMed ID: 28294419
    [No Abstract]   [Full Text] [Related]  

  • 7. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
    Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
    An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
    Pavone PS; Lovati S; Scarcella G; Milani M
    Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
    [No Abstract]   [Full Text] [Related]  

  • 10. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingenol mebutate-mediated reduction in p53-positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses.
    Grandi V; di Gennaro P; Torrigiani S; Basco L; Lastrucci I; Pimpinelli N
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1297-1303. PubMed ID: 30801837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
    Fernandez Figueras MT
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
    Deltondo JA; Helm KF
    G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.
    Apalla Z; Sotiriou E; Chovarda E; Lefaki I; Devliotou-Panagiotidou D; Ioannides D
    Br J Dermatol; 2010 Jan; 162(1):171-5. PubMed ID: 19863513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swiss clinical practice guidelines on field cancerization of the skin.
    Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
    Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.